SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

GE Healthcare Phase 2 Results Support Mangaciclanol's Advancement to Phase 3

Phase 2 results support advancing mangaciclanol into Phase 3 of the LUMINA trial.

GEHC

Related stories